<DOC>
	<DOCNO>NCT02639767</DOCNO>
	<brief_summary>The purpose study evaluate safety combine chemotherapy different dos specific type radiation therapy deliver entire lining lung find effect , , people . This radiation technique call pleural intensity modulate radiation therapy ( IMRT ) . IMRT specifically target line lung ( pleura ) cancer reduces risk damage lung . When give chemotherapy , pleural IMRT demonstrate promising result respect keep mesothelioma control longer . However , investigator want determine give pleural IMRT time chemotherapy safe . If safe , study do see chemotherapy pleural IMRT give time keep tumor control long period time chemotherapy follow pleural IMRT .</brief_summary>
	<brief_title>Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy Patients With Unresectable Malignant Pleural Mesothelioma</brief_title>
	<detailed_description />
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>Pathologically confirm diagnosis malignant pleural mesothelioma MSKCC No plan surgical resection Stage T14 , N03 , M0 No prior radiation therapy chest , breast supraclavicular fossa would limit radiation delivery full prescription dose Prior chemotherapy regimens ≤1 Age ≥18 year Karnofsky performance status ≥ 80 % Pulmonary function test follow : DLCO &gt; 50 % predicted Adequate hematologic , hepatic , renal function indicate follow laboratory value Absolute neutrophil count ≥ 1,500/mcL Platelets ≥ 100,000/mcL Calculated creatinine clearance ( CrCl ) ≥ 45mL/min ( use Cockcroft &amp; Gault method ) Serum total bilirubin ≤ 1.5 x upper limit normal ( ULN ) ( unless know Gilbert 's disease ) AST ( SGOT ) ALT ( SGPT ) ≤ 3.0 x ULN Pregnant lactate woman , men woman use effective contraception Patients active infection require systemic antibiotic , antiviral , antifungal treatment Patients concurrent active malignancy ( exception skin cancer ) Patients serious unstable medical illness Patients idiopathic pulmonary fibrosis Patients NYHA heart failure class &gt; 2 Patients one kidney ipsilateral mesothelioma Implanted pacemaker and/or defibrillator ipsilateral mesothelioma move Patients meet follow exclusion criterion exclude MRI portion : Metallic implant , e.g . pacemaker , defibrillator Unmanageable claustrophobia High risk nephrogenic systemic fibrosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Pemetrexed</keyword>
	<keyword>Cisplatin</keyword>
	<keyword>Intensity Modulated Radiation Therapy</keyword>
	<keyword>15-304</keyword>
</DOC>